Italic Health
AI-native SSO for healthcare
Website: https://italichealth.com/
Cover Block
PUBLIC
| Field | Value |
|---|---|
| Name | Italic Health |
| Tagline | AI-native SSO for healthcare |
| Headquarters | Miami, FL, United States |
| Founded | 2025 |
| Stage | Pre-Seed |
| Industry | Healthtech |
| Technology Type | AI / Machine Learning |
| Geography | North America |
| Founding Team | Solo Founder (Kyle Michelson) |
Links
PUBLIC
- Website: https://italichealth.com/
- LinkedIn (founder): https://www.linkedin.com/in/kylemichelson/
- Facebook: https://www.facebook.com/italichealth/
- PitchBook profile: https://pitchbook.com/profiles/company/1241970-67
Executive Summary
PUBLIC
Italic Health is a 2025-vintage Miami-based healthtech company building what its website and third-party profiles describe as the identity and memory layer for healthcare, starting with an AI-native single sign-on product [Italic Health; PitchBook]. The company is in its earliest commercial chapter, founded and led by Kyle Michelson, whose prior operating experience includes co-founding Getlabs, an at-home diagnostics company that raised a $3 million seed in 2021 and a $20 million Series A in 2022 [TechCrunch, April 2021; TechCrunch, February 2022]. The pitch sits at the intersection of two themes investors have been actively underwriting in 2025: vertical AI applied to regulated workflows, and identity infrastructure rebuilt for an agent-driven software stack [NVP Capital, 2025]. Public disclosures around funding, customers, and team size are limited, and PitchBook lists the company at pre-seed without a confirmed round [PitchBook]. Founder background and category timing are the most legible signals at this stage; product depth, design partner names, and capital structure are not yet public. Over the next 12 to 18 months, the watch items are a priced pre-seed or seed round, named provider or payer design partners, and any public detail on how the SSO product extends into the broader identity and memory layer the company describes.
Data Accuracy: YELLOW -- Founder, location, and founding year are corroborated by PitchBook, RocketReach, and the company website; funding and product specifics are not independently confirmed.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Pre-Seed |
| Industry / Vertical | Healthtech (identity infrastructure) |
| Technology Type | AI / Machine Learning |
| Geography | North America (Miami, FL) |
| Founding Team | Solo Founder |
Company Overview
PUBLIC
Italic Health was incorporated in 2025 and lists a 2026 copyright on its public site, consistent with a company that stood up its public presence in late 2025 [Italic Health; PitchBook]. The headquarters is Miami, Florida, and the corporate entity is referenced on the site as Italic Health, Inc. [Italic Health]. Public databases including PitchBook and RocketReach identify Kyle Michelson as Founder and CEO and do not list additional executives at the time of writing [PitchBook; RocketReach].
The company describes its scope as the identity and memory layer for healthcare, with an initial wedge product framed as AI-native single sign-on. That positioning, taken from the company's own summary as captured by third-party profilers, situates Italic Health upstream of clinical and administrative software rather than as a point application [RocketReach]. No press release, funding announcement, or customer logo has been surfaced in the public record reviewed for this report.
Milestones to date are limited to formation, the launch of the public website under the italichealth.com domain, and the founder's public association with the company on LinkedIn [Italic Health; LinkedIn]. Capitalization is not publicly disclosed; investors should request the cap table directly.
Data Accuracy: YELLOW -- Formation, location, and leadership confirmed by PitchBook, RocketReach, and the company site; milestone history is thin because the company is new.
Product and Technology
MIXED
Italic Health's public product description, as captured across the company website and third-party directories, centers on AI-native single sign-on for healthcare, positioned as the first surface of a broader identity and memory layer for the sector [PUBLIC] [Italic Health; RocketReach]. In healthcare IT, single sign-on is a mature category dominated by clinical context vendors that federate access across electronic health record systems, imaging, and ancillary clinical applications. The Italic Health framing departs from that legacy by foregrounding AI-native, suggesting the product is designed for environments where AI agents, copilots, and automated workflows act on behalf of clinicians and staff and therefore need identity, permission, and context handling that traditional SSO was not designed to deliver [PUBLIC].
The memory layer language in the company's own summary implies persistence of user, role, and contextual data across sessions and applications, which would be a meaningful extension beyond authentication into authorization, audit, and personalization [PUBLIC] [RocketReach]. No technical documentation, API reference, SOC 2 attestation, or HIPAA posture statement has been published in the sources reviewed [PRIVATE]. The technology stack and hosting model are not disclosed in any public source captured for this report; no engineering job postings were surfaced from the careers page or major applicant tracking system hosts that would allow inference [PRIVATE].
Given the early stage, the most defensible read is that Italic Health is in a pre-product or limited-design-partner phase, with a public narrative meant to attract pre-seed capital and initial provider conversations rather than to convert inbound enterprise demand. Buyers and investors evaluating the product should expect to receive most substantive detail under NDA.
Data Accuracy: ORANGE -- Product positioning is taken from the company's own summary via RocketReach and the website; no independent technical validation is publicly available.
Market Research and Opportunity
PUBLIC
Identity infrastructure for healthcare matters now because the workflow layer of the industry is being rewritten around AI agents, and the access, audit, and context primitives those agents require are not natively served by general-purpose SSO. NVP Capital's 2025 vertical AI review explicitly frames the current period as the deployment era for vertical AI, with healthcare cited among the sectors where regulated workflows are pulling AI into production rather than pilots [NVP Capital, 2025]. That deployment shift is the proximate tailwind for an AI-native identity layer: every additional AI agent operating against an electronic health record, scheduling system, or claims platform is a new principal that needs to be authenticated, authorized, and logged.
No named third-party report sizes the AI-native healthcare identity category specifically. As an analogous reference, the broader healthcare IT identity and access management market is well established and served by incumbents in clinical SSO and federated identity, while the horizontal workforce identity market is dominated by Okta, Microsoft Entra, and Ping. The opportunity Italic Health appears to be underwriting is that neither the legacy healthcare-specific SSO vendors nor the horizontal identity platforms have rebuilt their primitives for AI agents in a HIPAA-regulated context, leaving room for a vertical-native entrant.
| Sizing reference | Figure | Source |
|---|---|---|
| Vertical AI deployment era thesis (qualitative) | Healthcare named as priority sector | [NVP Capital, 2025] |
| Y Combinator digital health portfolio | 98 digital health companies funded | [Y Combinator] |
The table above is intentionally narrow: only sizing-adjacent claims that appear in the cited research are included, and no TAM figure has been independently published for the AI-native healthcare identity wedge specifically. The analyst takeaway is that Italic Health is targeting a category whose existence is asserted by category investors and adjacent activity rather than by a discrete published market study, which is typical for infrastructure plays at the formation stage and is itself a feature of the opportunity rather than a defect.
Regulatory forces shape the demand curve directly. HIPAA, state-level privacy regimes, and the operational requirements of provider security teams set a high floor for any identity vendor that handles protected health information, which raises switching costs once a vendor is embedded but also extends sales cycles materially.
Data Accuracy: YELLOW -- Tailwind framing is supported by NVP Capital's 2025 review; specific TAM figures for the AI-native healthcare identity wedge are not publicly available.
Competitive Landscape
MIXED
Italic Health is positioning into a category whose incumbents were built for human users and whose horizontal challengers were not built for healthcare, which is the gap the company appears to be underwriting [PUBLIC].
The segment splits into three groups. First, legacy healthcare-specific identity and clinical context vendors that federate access across EHR and ancillary systems for clinicians; these companies have deep provider distribution, established security reviews, and entrenched integration footprints, but their architectures predate the agentic AI use case. Second, horizontal workforce identity platforms including Okta, Microsoft Entra, and Ping, which have the engineering depth and enterprise distribution to extend into AI agent identity but treat healthcare as one vertical among many and do not natively model clinical roles, PHI handling, or provider workflow context. Third, a fast-growing cohort of AI-native identity and agent authorization startups that are building generic primitives for non-human principals; these companies move quickly but lack the regulatory specificity that healthcare buyers require.
Where Italic Health could build a defensible edge is at the intersection of those three groups: a product designed from first principles for AI agents acting in HIPAA-regulated workflows, sold by a founder who has previously navigated provider procurement at Getlabs [TechCrunch, February 2022]. That edge is durable to the extent that the company secures early provider design partners and codifies regulatory posture (SOC 2, HITRUST, BAA-ready architecture) before horizontal incumbents extend into the vertical. The edge is perishable if Okta or Microsoft Entra ship credible AI agent identity features tied to healthcare-specific compliance packs before Italic Health reaches commercial scale.
The most acute exposure is distribution. Horizontal identity incumbents already sit inside the IT stack of nearly every large health system, and legacy clinical SSO vendors already sit inside the EHR. A new entrant has to win a security review, an integration slot, and a budget line that is typically already allocated. Over the next 18 months the plausible winner-if scenario is: Italic Health lands two or three named provider design partners, publishes a HIPAA and SOC 2 posture, and converts that into a priced seed round led by a vertical AI investor, at which point the category narrative consolidates around the company. The plausible loser-if scenario is: a horizontal identity incumbent ships an AI agent identity SKU with a healthcare compliance pack inside the same window, compressing the window during which Italic Health can establish category ownership.
Data Accuracy: ORANGE -- No competitors are named in the captured sources; segment structure is inferred from public category knowledge and from the NVP Capital 2025 vertical AI review.
Opportunity
PUBLIC
If Italic Health executes, the prize is becoming the default identity and memory substrate that every AI-native healthcare application is built on top of, a position with the same structural characteristics that made Okta a public company in horizontal workforce identity.
The headline opportunity. The single largest outcome Italic Health could plausibly reach is category ownership of AI-native identity for healthcare: the layer that every AI scribe, agentic workflow tool, revenue cycle copilot, and clinical decision support product authenticates and authorizes against. The cited evidence makes this reachable rather than aspirational for two reasons. First, NVP Capital's 2025 review explicitly identifies vertical AI deployment as the active investment theme of the year, with healthcare among the named sectors [NVP Capital, 2025]. Second, the founder has previously built and scaled a healthcare company through institutional rounds at Getlabs, which raised $3 million in 2021 and $20 million in 2022 and was profiled by Axios for its partnership-led go-to-market [TechCrunch, April 2021; TechCrunch, February 2022; Axios, November 2022]. The combination of a category that investors are actively funding and a founder with prior provider-facing operating reps is the minimum condition for a credible run at category ownership.
Growth scenarios.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Become the default identity layer for AI-native health software | Italic Health wins design-partner status with two or three vertical AI health startups and is bundled into their security posture | A priced seed round and a public reference customer | Vertical AI in healthcare is in active deployment per [NVP Capital, 2025] |
| Embed inside provider IT alongside legacy clinical SSO | Health systems adopt Italic Health for AI-agent access while retaining incumbent SSO for human clinicians | A named health system contract and a HIPAA / SOC 2 attestation | Founder previously sold into provider workflows at Getlabs [TechCrunch, February 2022] |
| Win the agent-identity standard for regulated verticals | Italic Health publishes an open spec for AI agent identity that other healthcare vendors adopt | A published reference implementation and an industry working group | Standards-setting plays are a recognized pattern in identity infrastructure |
What compounding looks like. The flywheel in identity infrastructure is well understood: each integration the platform ships becomes a switching cost for the customer and a distribution asset for the next customer, because new applications prefer to plug into the identity layer their buyers already trust. For Italic Health specifically, the memory layer language in the company's own description suggests an additional compounding vector: contextual data accumulated about users, roles, and workflows becomes more valuable per additional AI agent that consumes it, which is a data network effect that legacy SSO vendors do not have [Italic Health; RocketReach]. There is no public evidence yet that this flywheel is turning; the claim at pre-seed is that the architecture is designed to support it.
The size of the win. Okta is the most cited public comparable in workforce identity and has historically traded as a multi-billion-dollar public company; vertical-native identity plays in regulated sectors have generally commanded premium multiples when acquired by horizontal incumbents. If the first scenario above plays out and Italic Health becomes the embedded identity layer for the AI-native healthcare software cohort, the realistic outcome window spans a strategic acquisition by a horizontal identity incumbent or an EHR vendor, or an independent path to a vertical-software public listing (scenario, not a forecast). At pre-seed, the right way to read this is as a category whose ceiling is high enough to justify institutional underwriting, not as a forecast of any specific outcome.
Data Accuracy: YELLOW -- Scenario logic is grounded in the NVP Capital 2025 review and the founder's prior Getlabs rounds; specific outcome valuations are scenario framing rather than forecasts.
Sources
PUBLIC
[PitchBook] Italic Health 2026 Company Profile: Valuation, Funding & Investors | https://pitchbook.com/profiles/company/1241970-67
[LinkedIn] Kyle Michelson, Italic Health | https://www.linkedin.com/in/kylemichelson/
[Italic Health] Italic Health company website | https://italichealth.com/
[RocketReach] Kyle Michelson, Italic Health Founder and CEO Contact Information | https://rocketreach.co/kyle-michelson-email_736443
[RocketReach] Italic Health Information | https://rocketreach.co/italic-health-profile_b69fabaec8f791e9
[TechCrunch, April 2021] Getlabs, an at-home medical labs company, launches with a $3 million raise | https://techcrunch.com/2021/04/13/2137488/
[TechCrunch, February 2022] Getlabs will build out its at-home blood testing network with $20M Series A | https://techcrunch.com/2022/02/03/getlabs-at-home-blood-tests-20m-series-a/
[Axios, November 2022] A very friendly elephant: Market conditions see health techs bypass M&A for partnerships | https://www.axios.com/pro/health-tech-deals/2022/11/29/health-tech-partnerships-sidestep-mergers-acquisitions
[NVP Capital, 2025] NVP Capital 2025 Year in Review: Vertical AI in the Deployment Era | https://nvpcap.com/blog/nvp-capital-2025-vertical-ai-year-in-review/
[Y Combinator] Digital Health Startups funded by Y Combinator | https://www.ycombinator.com/companies/industry/digital-health
[Facebook] Italic Health (@italichealth) | https://www.facebook.com/italichealth/
Articles about Italic Health
- Italic Health Wants to Be the Login Button on Every Clinician's Workstation — Kyle Michelson's new Miami startup is building an AI-native single sign-on layer for healthcare, starting from a blank slate in 2025.